RFK Jr. & claimed regenerative peptides like BPC 157 The Niche When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions FDA considers adding a dozen peptides to its bulk drug compounding list RAPS Peptides in 2026, What the FDA Review Means Olympia Pharmaceuticals Mark your calendar. July 23 24. FDA advisory committee reviewing BPC 157, TB 500, MOTS C, semax, epitalon, KPV, and DSIP for the 503A compounding list. The peptide landscape could shift significantly.